Pentwater Capital Management LP Calliditas Therapeutics Ab Transaction History

Pentwater Capital Management LP

  • $9.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$15.04 - $26.32 $691,840 - $1.21 Million
-46,000 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$21.03 - $33.19 $84,120 - $132,760
-4,000 Reduced 8.0%
46,000 $995,000
Q4 2020

Feb 16, 2021
SELL
$23.34 - $36.65 $258,700 - $406,228
-11,084 Reduced 18.15%
50,000 $1.68 Million
Q3 2020

Nov 16, 2020
SELL
$21.61 - $25.69 $106,234 - $126,292
-4,916 Reduced 7.45%
61,084 $1.47 Million
Q2 2020

Aug 14, 2020
BUY
$19.17 - $23.2 $1.27 Million - $1.53 Million
66,000 New
66,000 $1.53 Million

Others Institutions Holding CALT

# of Institutions
6
Shares Held
20.3K
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Pentwater Capital Management LP Portfolio

Follow Pentwater Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pentwater Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Pentwater Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email